RecruitingNCT07539883

Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study

Official Title: Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study Using a Target Trial Emulation Approach


Sponsor

Seoul National University Bundang Hospital

Enrollment

360 participants

Start Date

Jan 22, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to evaluate the clinical effectiveness of the oXiris® hemofilter in patients with septic shock and acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). While some studies suggest that oXiris® may improve hemodynamic stability by removing endotoxins and cytokines, its impact on survival remains inconsistent.To provide more reliable causal evidence, this multicenter retrospective cohort study utilizes a Target Trial Emulation (TTE) approach. The study will compare patients treated with the oXiris® filter to those treated with standard CRRT filters, focusing on in-hospital mortality and other clinical outcomes such as fluid balance and vasopressor requirements.


Eligibility

Min Age: 19 Years

Inclusion Criteria3

  • Adults aged 19 years or older.
  • Admitted to the ICU with septic shock (Sepsis-3 criteria) between March 2021 and August 2025.
  • Required Continuous Renal Replacement Therapy (CRRT) due to acute kidney injury (AKI).

Exclusion Criteria3

  • Death or withdrawal of life-sustaining therapy within 48 hours of ICU admission.
  • Patients with End-Stage Renal Disease (ESRD).
  • Patients with missing critical covariates.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07539883


Related Trials